Cas:28467-22-3 1-[5-[(3-acetyl-4-hydroxyphenyl)methyl]-2-hydroxyphenyl]ethanone manufacturer & supplier

Chemical Name:1-[5-[(3-acetyl-4-hydroxyphenyl)methyl]-2-hydroxyphenyl]ethanone

CAS.NO:28467-22-3

Synonyms:Bis-(3-acetyl-4-hydroxyphenyl)-methane;3,3′-Diacetyl-4,4′-dihydroxydiphenylmethan;Bis-(3-acetyl-4-hydroxyphenyl)-methan;Ethanone,1,1′-[methylenebis(6-hydroxy-3,1-phenylene)]bis;1-[5-(3-Acetyl-4-hydroxy-benzyl)-2-hydroxy-phenyl]-ethanone;5,5′-methylenebis(2-hydroxyacetophenone)

Molecular Formula:C₁₇H₁₆O₄

Molecular Weight:284.30700

HS Code:2914400090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:478.1ºC at 760mmHg

Density:1.242g/cm3

Index of Refraction:1.61

PSA:74.60000

Exact Mass:284.10500

LogP:3.09380

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Bis-(3-acetyl-4-hydroxyphenyl)-methane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5,5′-methylenebis(2-hydroxyacetophenone) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-[5-(3-Acetyl-4-hydroxy-benzyl)-2-hydroxy-phenyl]-ethanone Use and application,5,5′-methylenebis(2-hydroxyacetophenone) technical grade,usp/ep/jp grade.

Related News: She said she revealed her diagnosis in the interest of transparency but in truth really mostly as a shoutout to early diagnosis,” and wanted to “urge women to educate themselves on this disease; to get all the regular screenings and scans that you can; to always listen to your bodies; and of course to ensure that your legitimate medical concerns are not dismissed or diminished. 1-[5-[(3-acetyl-4-hydroxyphenyl)methyl]-2-hydroxyphenyl]ethanone manufacturer The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. 1-[5-[(3-acetyl-4-hydroxyphenyl)methyl]-2-hydroxyphenyl]ethanone supplier The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. 1-[5-[(3-acetyl-4-hydroxyphenyl)methyl]-2-hydroxyphenyl]ethanone vendor ��Ultimately, this is a public health decision,�� she said, adding that the restrictions were precautionary measures to keep the country virus-free and contain the worldwide outbreak. 1-[5-[(3-acetyl-4-hydroxyphenyl)methyl]-2-hydroxyphenyl]ethanone factory A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory.